Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [8]
- Comments [0]
- Validations
- Western blot [1]
- Immunoprecipitation [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 25090-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- PCDH9 antibody
- Antibody type
- Polyclonal
- Description
- PCDH9 antibody (Cat. #25090-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IHC, IP, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references RNF145 Promotes Hepatocellular Carcinoma Metastasis through Ubiquitination and Degradation of PCDH9.
The lncRNA MIR22HG suppresses prostate cancer cell proliferation, migration, and epithelial-mesenchymal transition via the miR-4428/PCDH9 axis.
Spatial and Temporal Expression Patterns of EDA2R, PCDH9, and TRAF7 in Yotari (Dab1(-/-)) Mice: Implicationsfor Understanding CAKUT Pathogenesis.
Unraveling the Role of PCDH9 in Breast Cancer and Identifying Therapeutic Strategies for PCDH9-Deficient Tumors.
Expression of Congenital Anomalies of the Kidney and Urinary Tract (CAKUT) Candidate Genes EDA2R, PCDH9, and TRAF7 in Normal Human Kidney Development and CAKUT.
Longitudinal single-cell transcriptional dynamics throughout neurodegeneration in SCA1.
Disruption of the Autism-Associated Pcdh9 Gene Leads to Transcriptional Alterations, Synapse Overgrowth, and Defective Network Activity in the CA1.
MiR-200a-3p promoted the malignant behaviors of ovarian cancer cells through regulating PCDH9.
Zhang H, Xu Z, Xu Y, Li M, Liu L, He C, Zhong W, Qiu J
Oncology research 2026;34(2):24
Oncology research 2026;34(2):24
The lncRNA MIR22HG suppresses prostate cancer cell proliferation, migration, and epithelial-mesenchymal transition via the miR-4428/PCDH9 axis.
Li A, Sun W, Shao S, Qiu X, Hu J, Cui F
Translational cancer research 2025 May 30;14(5):3133-3148
Translational cancer research 2025 May 30;14(5):3133-3148
Spatial and Temporal Expression Patterns of EDA2R, PCDH9, and TRAF7 in Yotari (Dab1(-/-)) Mice: Implicationsfor Understanding CAKUT Pathogenesis.
Komić J, Kelam N, Racetin A, Filipović N, Saraga-Babić M, Ihara D, Katsuyama Y, Vukojević K
International journal of molecular sciences 2025 Jul 3;26(13)
International journal of molecular sciences 2025 Jul 3;26(13)
Unraveling the Role of PCDH9 in Breast Cancer and Identifying Therapeutic Strategies for PCDH9-Deficient Tumors.
Li R, Liu L, Liu Y, Tang J, Li J
Breast cancer (Dove Medical Press) 2024;16:583-593
Breast cancer (Dove Medical Press) 2024;16:583-593
Expression of Congenital Anomalies of the Kidney and Urinary Tract (CAKUT) Candidate Genes EDA2R, PCDH9, and TRAF7 in Normal Human Kidney Development and CAKUT.
Kelam J, Kelam N, Filipović N, Komić L, Racetin A, Komić D, Kostić S, Kuzmić Prusac I, Vukojević K
Genes 2024 May 28;15(6)
Genes 2024 May 28;15(6)
Longitudinal single-cell transcriptional dynamics throughout neurodegeneration in SCA1.
Tejwani L, Ravindra NG, Lee C, Cheng Y, Nguyen B, Luttik K, Ni L, Zhang S, Morrison LM, Gionco J, Xiang Y, Yoon J, Ro H, Haidery F, Grijalva RM, Bae E, Kim K, Martuscello RT, Orr HT, Zoghbi HY, McLoughlin HS, Ranum LPW, Shakkottai VG, Faust PL, Wang S, van Dijk D, Lim J
Neuron 2024 Feb 7;112(3):362-383.e15
Neuron 2024 Feb 7;112(3):362-383.e15
Disruption of the Autism-Associated Pcdh9 Gene Leads to Transcriptional Alterations, Synapse Overgrowth, and Defective Network Activity in the CA1.
Miozzo F, Murru L, Maiellano G, di Iasio I, Zippo AG, Zambrano Avendano A, Metodieva VD, Riccardi S, D'Aliberti D, Spinelli S, Canu T, Chaabane L, Hirano S, Kas MJH, Francolini M, Piazza R, Moretto E, Passafaro M
The Journal of neuroscience : the official journal of the Society for Neuroscience 2024 Dec 11;44(50)
The Journal of neuroscience : the official journal of the Society for Neuroscience 2024 Dec 11;44(50)
MiR-200a-3p promoted the malignant behaviors of ovarian cancer cells through regulating PCDH9.
Shi C, Yang Y, Zhang L, Yu J, Qin S, Xu H, Gao Y
OncoTargets and therapy 2019;12:8329-8338
OncoTargets and therapy 2019;12:8329-8338
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- mouse brain tissue were subjected to SDS PAGE followed by western blot with 25090-1-AP( PCDH9 Antibody) at dilution of 1:600
- Sample type
- tissue
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The PCDH9 antibody from Proteintech is a rabbit polyclonal antibody to a fusion protein of human PCDH9. This antibody recognizes human, mouse, rat antigen. The PCDH9 antibody has been validated for the following applications: ELISA, WB, IP analysis.
